In sum, the findings of this retrospective polyps study combined with the novel CDH1 and NRAS germline mutations found in the CRC groups emphasize the existence of the Taiwanese-specific genome and provided candidate genes for cancer risk assessment in the general population. The gene discussed is NRAS; the disease is cancer.